Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
15 Novembro 2022 - 9:44AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of November 2022
Commission File Number: 001-39600
EQONEX
LIMITED
(Translation
of registrant’s name into English)
118
Piccadilly
Mayfair, London WIJ 7NW
United
Kingdom
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION
CONTAINED IN THIS REPORT ON FORM 6-K
EQONEX
LIMITED (the “Company”) will hold its Annual General Meeting of Shareholders (the “Annual General Meeting”)
on November 29, 2022 (Tuesday) at 8:00 P.M. (Singapore Time) / 8:00 A.M. (Eastern Time). In connection with the Annual General Meeting,
the Company will, on or about November 14, distribute to its shareholders of record and beneficial shareholders as of the record date
of September 30, 2022: (i) a Proxy Statement, dated November 14, 2022 (the “Proxy Statement”) and (ii) a Notice of
Annual General Meeting of Shareholders, dated November 14, 2022 (each of the foregoing as attached hereto as Exhibit 99.1 and 99.2, respectively).
The Company has also made available a Proxy Card, attached as Exhibit 99.3 to this Report on Form 6-K, which is to be completed according
to the instructions set forth in the Proxy Statement; holders of the Company’s shares should review the instructions set forth
in the Proxy Statement in order to exercise their voting rights with respect to their shares in the Company at the Annual General Meeting.
EXHIBIT
INDEX
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
EQONEX LIMITED |
|
|
|
Date:
November 15, 2022 |
By: |
/s/
Daniel Ling |
|
Name: |
Daniel
Ling |
|
Title: |
Chief
Financial Officer |
Eqonex (NASDAQ:EQOS)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Eqonex (NASDAQ:EQOS)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025